OP Mortgage Bank: Half-year Financial Report 1 January–30 June 2024
July 24, 2024 03:00 ET
|
OP Mortgage Bank plc
OP Mortgage BankHalf-year Financial Report 1 January–30 June 2024Stock Exchange Release 24 July 2024 at 10.00 EEST OP Mortgage Bank: Half-year Financial Report 1 January–30 June 2024 ...
Treatment.com AI Provides an Update on the Status of Exercised Warrants
July 24, 2024 03:00 ET
|
Treatment.com AI Inc.
●~800,000 warrants exercised since free trading was announced raising close to half a million dollars. ●Remaining warrants could bring over $2 million in additional funds. ●Robust acquisition...
FDH Aero Signs Agreement to Support South Korea’s Aerospace Operations
July 24, 2024 03:00 ET
|
FDH Aero
Agreement with Sacheon city further strengthens FDH Aero’s presence in the APAC region and bolsters Korea’s nascent space industry First aerospace supplier to sign an MOU with Sacheon city COMMERCE,...
Global Carpet Backing Materials Market Size To Worth USD 14.89 Billion By 2033 | CAGR Of 5.00%
July 24, 2024 03:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , July 24, 2024 (GLOBE NEWSWIRE) -- The Global Carpet Backing Materials Market Size is Expected to Grow from USD 9.14 Billion in 2023 to USD 14.89 Billion by 2033, at a CAGR...
Nokia Corporation - Managers' transactions (Uitto)
July 24, 2024 03:00 ET
|
Nokia Oyj
Nokia CorporationManagers’ transactions24 July 2024 at 10:00 EESTNokia Corporation - Managers' transactions (Uitto) Transaction notification under Article 19 of EU Market Abuse...
Starkes Wachstum bei Fondsmanagern in der DACH-Region signalisiert Öffnung für Privatkapital – wie aus einem Bericht von Preqin hervorgeht
July 24, 2024 03:00 ET
|
Preqin Ltd
FRANKFURT, Deutschland, July 24, 2024 (GLOBE NEWSWIRE) -- Preqin, der weltweit führende Anbieter von Daten, Tools und Erkenntnissen zu alternativen Anlagen, veröffentlichte heute seinen Bericht...
OSE Immunotherapeutics Announces Positive Efficacy Results for Lusvertikimab in the Phase 2 trial for the treatment of Ulcerative Colitis
July 24, 2024 02:55 ET
|
OSE Immunotherapeutics
OSE Immunotherapeutics Announces Positive Efficacy Results for Lusvertikimab in the Phase 2 trial for the treatment of Ulcerative Colitis Lusvertikimab demonstrates significant efficacy during the...
Anmodning om suspension for afdelinger under Investeringsforeningen BankInvest
July 24, 2024 02:52 ET
|
Investeringsforeningen BankInvest
På grund af lukkedage i underliggende markeder anmodes om suspension af nedenstående afdelinger. Afdeling ISIN Short name Emerging Markets Aktier Vontobel/BankInvest A DK0060516854 ...
Prota Therapeutics Strengthens Board with Appointment of Global Biotech Expert Patrick Machado
July 24, 2024 02:50 ET
|
Prota Therapeutics
Prota Therapeutics appoints Patrick Machado as Chair to its Board of Directors.Patrick has a successful 30-year track record in biotech across North America and EuropePatrick is motivated by Prota's...
Correction: Harju Elekter Group financial results, 1-6/2024
July 24, 2024 02:39 ET
|
AS Harju Elekter Group.
Correction: Harju Elekter Group financial results, 1-6/2024 In today's stock exchange announcement and financial report (page 7), in the table reflecting the main indicators, there was an error in...